(NASDAQ:TLX), NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) between February 21, 2025 and August 28, 2025, both dates inclusive (the “Class Period”), of the important January 9, 2026 lead plaintiff deadline in the securities […]

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX GlobeNewswire December 08, 2025 NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Telix Pharmaceuticals

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Leqembi® (lecanemab), has been included in the “Commercial Insurance Innovative Drug List”, recently introduced by the National Healthcare Security Administration (NHSA) of China. The inclusion of Leqembi in this list marks a meaningful step toward expanding access to early Alzheimer's Disease (AD) treatment

Kiwetinohk Energy Corp. (TSX: KEC) (“Kiwetinohk” or the “Company”) announces that independent proxy advisory firms, including Institutional Shareholder Services Inc. (“ISS”), have recommended that holders (“Shareholders”) of the Company's common shares (the “Shares”) vote FOR the special resolution (the “Arrangement Resolution”) approving the proposed statutory plan of arrangement (the “Arrangement”) involving Kiwetinohk, the Shareholders and

Calgary, Alberta–(Newsfile Corp. – December 8, 2025) – BLOK Digital Ltd. (NEX: BLOK.H) (OTC Pink: BLVDF) (FSE: BD4) (the “Company“) is pleased to announce that, further to its November 13, 2025 press release announcing a non-brokered private placement of up to 10,000,000 common shares of the Company (“Shares“) at a price of $0.10 per share

The new premium “ski-in/ski-out” resort, located just steps away from the charming village of Tremblant, marks a major expansion for the brand in Canada following the success of Club Med Québec Charlevoix. Club Med, the world leader in premium all-inclusive mountain and beach resorts, today announced the development of Club Med Tremblant, marking a strategic

— Kia PV5 Cargo earns the top five-star rating in the 2025 Euro NCAP Commercial Van Safety assessment — Strong performance across key categories, including Occupant Protection, Safety Assist/Crash Avoidance and Post-Crash Safety — Standard ADAS technologies – includingAEB, Lane Support System and Speed Assistance System – deliver high performance in demanding real-world test scenarios

First Horizon Bank (NYSE:FHN) announced today that Todd Warrick, Executive Vice President and Corporate and Commercial Market Leader, has been promoted to Triangle Market President for the Mid-Atlantic region. He will continue to report to Laura Bunn, Mid-Atlantic Regional President, and will remain responsible for leading First Horizon's Mid-Atlantic corporate and commercial banking, associate engagement

(NASDAQ:BIIB), TOKYO and CAMBRIDGE, Mass., Dec. 08, 2025 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that anti-AB protofibril* antibody “LEQEMBI(R)” (brand name in China: “ä¹æ„ä¿(R)“, generic name: lecanemab), has been included in the “Commercial

“LEQEMBI(R)” (lecanemab) for the Treatment of Early Alzheimer's Disease Included in China's Commercial Insurance Innovative Drug List GlobeNewswire December 08, 2025 TOKYO and CAMBRIDGE, Mass., Dec. 08, 2025 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced